Docket Room
HR 7902·Federal·house

Safeguarding Women from Chemical Abortion Act

In CommitteeFiled Mar 12, 2026
Sponsor: Rep. Harshbarger, Diana [R-TN-1] (R)
Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Mar 12, 2026

Summary

The bill declares the FDA's approval of the abortion medication mifepristone withdrawn, making its sale for pregnancy termination illegal. It creates a federal civil claim that allows any woman who suffers physical or mental harm from the drug to sue the drug's manufacturers for compensation, including punitive damages and attorney fees. The measure applies only to manufacturers, not to distributors or other parties.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HR 7902 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice